HUANG DENNIS KARL (See Remarks) sold 0.5% of their position (389.00 shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $17.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2023ACC: 0001209191-23-016043
Officer· See Remarks
Since Mar 2026
+53.08K
Net shares
Net buyer
$501.6K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
64.06K acquired · 10.99K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+2.66K
Price / share
—
Trade value
—
% of position
5.2%
3/1/2023
51.04K→53.70K
Common Stock
Direct
Shares
+22K
Price / share
—
Trade value
—
% of position
41.0%
3/1/2023
53.70K→75.70K
Common Stock
Direct
Shares
−389.00
Price / share
$45.65
Trade value
$17.76K
% of position
0.5%
3/1/2023
75.70K→75.31K
Common Stock
Direct
Shares
−10.60K
Price / share
$45.65
Trade value
$483.84K
% of position
14.1%
3/1/2023
75.31K→64.72K
Total
Net shares
+13.68K
Net value
-$501.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2023 | A · Award | +2.66K | — | — | 5.2% | 51.04K | 53.70K |
| Common Stock Direct | 3/1/2023 | A · Award | +22K | — | — | 41.0% | 53.70K | 75.70K |
| Common Stock Direct | 3/1/2023 | S · Sale | −389.00 | $45.65 | $17.76K | 0.5% | 75.70K | 75.31K |
| Common Stock Direct | 3/1/2023 | D · Disposition | −10.60K | $45.65 | $483.84K | 14.1% | 75.31K | 64.72K |
| Total | +13.68K | -$501.60K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
39.40K shares
Shares
+39.40K
Strike price
45.65
Held after
39.40K
Exercisable
—
3/1/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock39.40K shares | 3/1/2023 | A · Award | +39.40K | 45.65 | — | 39.40K |